Loading clinical trials...
Loading clinical trials...
Pro-inflammatory cytokines, which are elevated in pro-inflammatory disease states (e.g., type II diabetes mellitus \[T2DM\], irritable bowel diseases \[IBD\], and end stage renal disease \[ESRD\]) hav...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Indiana University
NCT07545772 · Irritable Bowel Syndrome, Constipation
NCT06639984 · Irritable Bowel Syndrome
NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more
NCT06847360 · Pain, Chronic, Irritable Bowel Syndrome, and more
NCT07112339 · Diabetes Mellitus, Type 2
Indiana University Hospital
Indianapolis, Indiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions